Our further studies showed that GCTs are derived from single mutant GCs that escape immune surveillance by expressing higher levels of Cd47 and Cd24a, while blocking CD47 in mice bearing GCTs efficiently decreases tumor size. This evidence concerns the gene CD47 and neoplasm.